Header cover image

U.S. Pharmaceuticals & Biotech Transformational Technology

UPDATED Nov 08, 2023

From healthcare tech to software services, these companies are riding the trend of changing consumer digital lifestyles and the proliferation of technology.

15 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	CPRXCatalyst Pharmaceuticals	US$12.54	-0.8%	-13.6%	US$1.4b	US$23.30	PE11.6x	E20.4%	n/a
	ARCTArcturus Therapeutics Holdings	US$19.40	3.4%	-8.0%	US$521.1m	US$60.56	PE6.4x	E39.9%	n/a
	NBIXNeurocrine Biosciences	US$115.39	3.5%	-5.7%	US$11.5b	US$136.76	PE59.4x	E36.2%	n/a
	PLXProtalix BioTherapeutics	US$1.37	-15.4%	34.3%	US$109.4m	US$13.00	PE9.4x	E90.5%	n/a
	HRMYHarmony Biosciences Holdings	US$23.93	-2.8%	-59.2%	US$1.4b	US$40.78	PE9.3x	E30.5%	n/a
	INCYIncyte	US$54.06	-0.6%	-30.0%	US$12.3b	US$77.91	PE28.5x	E29.5%	n/a
	BMRNBioMarin Pharmaceutical	US$85.51	1.8%	5.7%	US$16.1b	US$110.92	PE109.6x	E40.6%	n/a
	HALOHalozyme Therapeutics	US$36.75	9.7%	-26.1%	US$5.1b	US$51.27	PE19.1x	E23.9%	n/a
	MEDPMedpace Holdings	US$275.37	9.4%	34.0%	US$8.4b	US$278.60	PE30.9x	E14.6%	n/a
	PCRXPacira BioSciences	US$29.92	5.7%	-38.9%	US$1.4b	US$49.11	PE199x	E37.2%	n/a
	CORTCorcept Therapeutics	US$25.76	-8.3%	4.9%	US$2.7b	US$36.83	PE29.2x	E28.4%	n/a
	DVAXDynavax Technologies	US$13.29	-5.7%	11.1%	US$1.7b	US$25.00	PE28.1x	E35.8%	n/a
	MRKMerck	US$104.40	1.5%	2.8%	US$263.5b	US$123.90	PE57.4x	E33.5%	2.8%
	EXELExelixis	US$20.74	-1.3%	26.5%	US$6.6b	US$25.75	PE70x	E34.0%	n/a
	LLYEli Lilly	US$619.13	11.7%	70.4%	US$539.5b	US$609.97	PE111.6x	E31.5%	0.7%

Page 1 of 1